论文部分内容阅读
目的探讨布地奈德雾化吸入治疗小儿肺炎的临床效果。方法选择2010年12月至2013年7月小儿肺炎患者130例,随机分成对照组和观察组,每组65例,对照组接受肺炎的常规治疗,观察组同时联合布地奈德雾化吸入治疗,对比两组患儿发热、气喘与咳嗽等症状改善、肺部啰音消失、住院时间,及治疗有效率。结果观察组发热、气喘与咳嗽等症状改善、肺部啰音消失、住院天数显著短于对照组,差异有统计学意义(P<0.05),两组均未见明显的不良反应,观察组治疗有效率(93.8%)优于对照组(78.5%),差异有统计学意义(P<0.05)。结论常规基础治疗的同时联合布地奈德雾化吸入治疗小儿肺炎能够促进患者症状体征的缓解改善、促进患儿的预后,疗效确切且安全可靠,具有较高的临床应用价值。
Objective To investigate the clinical efficacy of budesonide inhalation in treating children with pneumonia. Methods 130 patients with pneumonia from December 2010 to July 2013 were randomly divided into control group and observation group, 65 cases in each group. The control group received routine treatment of pneumonia. The observation group was treated with budesonide inhalation, Compared two groups of children with fever, asthma and cough and other symptoms improved, pulmonary rales disappeared, hospital stay, and treatment efficiency. Results In the observation group, the symptoms of fever, asthma and cough were improved, the pulmonary rales disappeared and the number of days of hospitalization was significantly shorter than that of the control group (P <0.05), and no adverse reactions were observed in the observation group The effective rate (93.8%) was better than that of the control group (78.5%), the difference was statistically significant (P <0.05). Conclusion Conventional basic treatment combined with budesonide atomization inhalation in children with pneumonia can improve the relief of symptoms and signs in patients and promote the prognosis of children with definite and safe curative effect and high clinical value.